Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Oxford BioMedica ( (GB:OXB) ) just unveiled an update.
Oxford BioMedica PLC announced a change in major holdings, as Ameriprise Financial, Inc., a US-based company, has altered its voting rights in the company. The percentage of voting rights held by Ameriprise Financial decreased from 5.099% to 3.886%, signaling a shift in their investment strategy. This change may impact the company’s shareholder dynamics and influence future decisions, although the specific implications for stakeholders remain unspecified.
More about Oxford BioMedica
Oxford BioMedica PLC is a UK-based company operating in the biotechnology industry, specializing in the development and commercialization of gene and cell therapy products.
YTD Price Performance: -0.57%
Average Trading Volume: 7,043
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $516.1M
For an in-depth examination of OXB stock, go to TipRanks’ Stock Analysis page.
